Cargando…

Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV(1) decline: results from COPDGene and SPIROMICS

Purpose: The purpose of this study was to train and validate machine learning models for predicting rapid decline of forced expiratory volume in 1 s (FEV(1)) in individuals with a smoking history at-risk-for chronic obstructive pulmonary disease (COPD), Global Initiative for Chronic Obstructive Lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jennifer M., Labaki, Wassim W., Murray, Susan, Martinez, Fernando J., Curtis, Jeffrey L., Hoffman, Eric A., Ram, Sundaresh, Bell, Alexander J., Galban, Craig J., Han, MeiLan K., Hatt, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161244/ https://www.ncbi.nlm.nih.gov/pubmed/37153221 http://dx.doi.org/10.3389/fphys.2023.1144192

Ejemplares similares

Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts
por: Fawzy, Ashraf, et al.
Publicado: (2018)

Correcting Nonpathological Variation in Longitudinal Parametric Response Maps of CT Scans in COPD Subjects: SPIROMICS
por: Fernández-Baldera, Antonio, et al.
Publicado: (2017)

CT-Based Commercial Software Applications: Improving Patient Care Through Accurate COPD Subtyping
por: Wang, Jennifer M, et al.
Publicado: (2022)

Relationship between diffusion capacity and small airway abnormality in COPDGene
por: Criner, Rachel N., et al.
Publicado: (2019)

Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort
por: Zhang, William Z., et al.
Publicado: (2021)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort
por: Han, MeiLan K., et al.
Publicado: (2017)

Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS
por: Putcha, Nirupama, et al.
Publicado: (2018)

The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS
por: Wells, J. Michael, et al.
Publicado: (2019)

Quantitative CT of Normal Lung Parenchyma and Small Airways Disease Topologies are Associated With COPD Severity and Progression
por: Bell, Alexander J., et al.
Publicado: (2023)

Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS
por: Zhang, William Z., et al.
Publicado: (2020)

Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort
por: Opron, Kristopher, et al.
Publicado: (2021)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort
por: Cooper, Christopher B, et al.
Publicado: (2020)

Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort
por: Bhatt, Surya P., et al.
Publicado: (2018)

Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort
por: Busch, Robert, et al.
Publicado: (2016)

Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study
por: Hansel, Nadia N, et al.
Publicado: (2017)

Quantitative CT Correlates with Local Inflammation in Lung of Patients with Subtypes of Chronic Lung Allograft Dysfunction
por: Ram, Sundaresh, et al.
Publicado: (2022)

Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study
por: Labaki, Wassim W., et al.
Publicado: (2019)

Sputum or blood eosinophil association with clinical measures of COPD severity in the SPIROMICS cohort
por: Hastie, AT, et al.
Publicado: (2017)

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis
por: Barjaktarevic, Igor Z, et al.
Publicado: (2019)

Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD
por: Rosso, Aldana, et al.
Publicado: (2022)

Impact of bronchiectasis on the frequency and severity of respiratory exacerbations in COPD
por: Labaki, Wassim W, et al.
Publicado: (2018)

Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study
por: Kim, Victor, et al.
Publicado: (2014)

Accelerated FEV(1) decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
por: Whittaker, Hannah R., et al.
Publicado: (2021)

Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies
por: Moll, Matthew, et al.
Publicado: (2020)

Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene
por: Wan, Emily S, et al.
Publicado: (2014)

Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS
por: Tejwani, Vickram, et al.
Publicado: (2022)

Impact of self-reported Gastroesophageal reflux disease in subjects from COPDGene cohort
por: Martinez, Carlos H, et al.
Publicado: (2014)

Principal component analysis of flow-volume curves in COPDGene to link spirometry with phenotypes of COPD
por: Verstraete, Kenneth, et al.
Publicado: (2023)

Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
por: Zou, Chunrui, et al.
Publicado: (2021)

Low FEV1 Is Associated With Increased Risk Of Cachexia In COPD Patients
por: Mokari-Yamchi, Amin, et al.
Publicado: (2019)

CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study
por: Lynch, David A., et al.
Publicado: (2018)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort
por: Stott-Miller, Marni, et al.
Publicado: (2020)

Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study
por: Hayden, Lystra P., et al.
Publicado: (2015)

Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort
por: Baldomero, Arianne K., et al.
Publicado: (2020)

Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
por: Haghighi, Babak, et al.
Publicado: (2018)

Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS)
por: Haghighi, Babak, et al.
Publicado: (2019)

Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?
por: Wang, Jennifer M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f8id4n1sfpqk47fcnull74a7q1